Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
H ShengD S Warner

Abstract

Apolipoprotein E (apoE), a 34-KD glycosylated lipid-binding protein, is expressed as three common isoforms in humans (E2, E3, or E4). Clinical evidence suggests that the apoE genotype (APOE) may be a risk factor for poor outcome after acute central nervous system injury. This was examined further in transgenic mice constructed with the human APOE3 or APOE4 gene under the control of human promoter and tissue expression elements. Presence of human apoE3 and apoE4 proteins in brains of human APOE homozygous transgenic mice was confirmed by Western blotting. APOE3 (n = 12) and APOE4 (n = 10) mice underwent 60 minutes of middle cerebral artery occlusion. After 24-hour recovery, infarct size was measured. Infarct volumes (mean +/- standard deviation) were smaller in the APOE3 group (cortex: APOE3 = 18 +/- 4 mm3; APOE4 = 30 +/- 11 mm3, P = 0.04; subcortex: APOE3 = 12 +/- 4 mm3; APOE4 = 18 +/- 4 mm3, P = 0.003). Hemiparesis was less severe in APOE3 mice (P = 0.02). These data indicate that human isoform-specific effects of apoE are relevant to acute pathomechanisms of focal ischemic brain damage when examined in the mouse. APOE transgenic mice may provide an appropriate model to examine the mechanistic basis for the differential effect...Continue Reading

References

Sep 1, 1991·Brain Research. Molecular Brain Research·J PoirierC E Finch
Jan 1, 1989·Stroke; a Journal of Cerebral Circulation·E Z LongaR Cummins
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·T B RajavashisthA J Lusis
Jul 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·J H Skene, E M Shooter
Dec 1, 1995·Experimental Neurology·E MasliahA D Roses
Oct 10, 1995·Proceedings of the National Academy of Sciences of the United States of America·D M HoltzmanA L Schwartz
Jul 1, 1995·Nature Medicine·A D Roses, A Saunders
Aug 26, 1995·Lancet·M J AlbertsA D Roses
Jul 1, 1995·Revista clínica española·S Giménez-Roldán
May 1, 1995·The Annals of Thoracic Surgery·M F NewmanE P Mahanna
Jun 30, 1994·Biochemical and Biophysical Research Communications·T HayekM Aviram
Aug 1, 1994·Stroke; a Journal of Cerebral Circulation·G Y Yang, A L Betz
Sep 1, 1994·Journal of Neuropathology and Experimental Neurology·S H HanD E Schmechel
Jan 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·R L ReddickN Maeda
Jul 1, 1993·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·F C BaroneR N Willette
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Aug 1, 1996·Stroke; a Journal of Cerebral Circulation·H BasunM Viitanen
May 1, 1996·Brain Research. Molecular Brain Research·S M AliD B Carter
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·P E Schauwecker, O Steward
Jun 1, 1997·Journal of Neuroimmunology·D T LaskowitzW D Matthew
Jul 1, 1997·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·D T LaskowitzD S Warner

❮ Previous
Next ❯

Citations

Oct 26, 1999·Journal of Neuroscience Research·L LomnitskiD M Michaelson
Dec 21, 2000·Current Atherosclerosis Reports·S H AhmedC Y Hsu
May 14, 2005·Brain Research. Brain Research Reviews·Chava B PocernichD Allan Butterfield
May 4, 2005·Protein Expression and Purification·Kevin PearsonW Sean Davidson
Dec 14, 2002·Journal of the Neurological Sciences·Joong-Seok KimJong-Won Kim
Mar 4, 2000·Neuropharmacology·A J HunterA A Parsons
Feb 13, 2001·Brain Research. Molecular Brain Research·C RamassamyJ Poirier
May 18, 1999·Neuroscience Letters·I VeinbergsE Masliah
Apr 2, 1999·Biochimica Et Biophysica Acta·L LomnitskiD M Michaelson
Nov 28, 2001·Journal of Neurotrauma·M Sasaki, L Dunn
Dec 14, 2002·Annals of the New York Academy of Sciences·Kazuo KitagawaTakehiko Yanagihara
Nov 10, 2001·Annual Review of Genomics and Human Genetics·R W Mahley, S C Rall
Aug 25, 2007·Pharmacogenomics·Daniel T Laskowitz, Michael P Vitek
Aug 31, 2000·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·L LomnitskiD M Michaelson
Mar 3, 2009·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Luigi A L Lanterna, F Biroli
May 12, 2009·Neurochemistry International·Nobuhiro OsadaYoshihisa Ito
Sep 1, 2011·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Rachel JamesKaren Horsburgh
Jul 23, 2009·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Karsten RuscherTadeusz Wieloch
Sep 13, 2005·Journal of Cardiac Surgery·Fatma Zekiye AskarTahir Yagdi
Jan 18, 2005·Neurobiology of Aging·Jae Hee KangFrancine Grodstein
Oct 19, 2006·Neurobiology of Aging·Bruce Teter
Nov 18, 2005·Neurobiology of Aging·Stephen W ScheffElliott J Mufson
May 19, 2007·Neurological Research·Brian E MaceDaniel T Laskowitz
Jul 16, 2002·Neurological Research·Augusto ParraDavid S Warner
Sep 17, 2015·Acta Neurologica Scandinavica·L Z CsajbokB Nellgård
Feb 13, 2001·Experimental Neurology·D T LaskowitzE R Bennett

❮ Previous
Next ❯

Methods Mentioned

BETA
Protein Assay
electrophoresis
transgenic

Software Mentioned

Image QuaNT

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.